T. Rowe Price Associates’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.04M | Buy |
17,968
+1,660
| +10% | +$189K | ﹤0.01% | 1628 |
|
|
2025
Q1 | $1.72M | Buy |
16,308
+790
| +5% | +$83.1K | ﹤0.01% | 1679 |
|
|
2024
Q4 | $1.66M | Buy |
15,518
+1,781
| +13% | +$191K | ﹤0.01% | 1722 |
|
|
2024
Q3 | $1.38M | Buy |
13,737
+146
| +1% | +$14.6K | ﹤0.01% | 1820 |
|
|
2024
Q2 | $1.15M | Buy |
13,591
+599
| +5% | +$50.6K | ﹤0.01% | 1837 |
|
|
2024
Q1 | $951K | Buy |
12,992
+610
| +5% | +$44.7K | ﹤0.01% | 1933 |
|
|
2023
Q4 | $885K | Buy |
12,382
+860
| +7% | +$61.5K | ﹤0.01% | 1923 |
|
|
2023
Q3 | $692K | Buy |
11,522
+1,104
| +11% | +$66.3K | ﹤0.01% | 1960 |
|
|
2023
Q2 | $752K | Buy |
10,418
+835
| +9% | +$60.3K | ﹤0.01% | 1943 |
|
|
2023
Q1 | $705K | Buy |
9,583
+1,087
| +13% | +$80K | ﹤0.01% | 1955 |
|
|
2022
Q4 | $568K | Sell |
8,496
-4,772
| -36% | -$319K | ﹤0.01% | 2077 |
|
|
2022
Q3 | $713K | Buy |
13,268
+2,058
| +18% | +$111K | ﹤0.01% | 1940 |
|
|
2022
Q2 | $624K | Sell |
11,210
-1,819
| -14% | -$101K | ﹤0.01% | 2119 |
|
|
2022
Q1 | $914K | Buy |
13,029
+1,003
| +8% | +$70.4K | ﹤0.01% | 2045 |
|
|
2021
Q4 | $1.16M | Sell |
12,026
-1,994
| -14% | -$192K | ﹤0.01% | 1950 |
|
|
2021
Q3 | $1.22M | Sell |
14,020
-994
| -7% | -$86.4K | ﹤0.01% | 1950 |
|
|
2021
Q2 | $1.23M | Sell |
15,014
-1,409
| -9% | -$115K | ﹤0.01% | 1977 |
|
|
2021
Q1 | $1.56M | Sell |
16,423
-85,877
| -84% | -$8.17M | ﹤0.01% | 1823 |
|
|
2020
Q4 | $6.35M | Sell |
102,300
-180,631
| -64% | -$11.2M | ﹤0.01% | 1412 |
|
|
2020
Q3 | $16.8M | Sell |
282,931
-191,724
| -40% | -$11.4M | ﹤0.01% | 1193 |
|
|
2020
Q2 | $33.1M | Sell |
474,655
-38,821
| -8% | -$2.71M | ﹤0.01% | 982 |
|
|
2020
Q1 | $23.3M | Sell |
513,476
-19,321
| -4% | -$877K | ﹤0.01% | 1018 |
|
|
2019
Q4 | $34.7M | Sell |
532,797
-14,603
| -3% | -$950K | ﹤0.01% | 1025 |
|
|
2019
Q3 | $34M | Sell |
547,400
-4,612
| -0.8% | -$286K | ﹤0.01% | 996 |
|
|
2019
Q2 | $39.3M | Buy |
552,012
+2,359
| +0.4% | +$168K | 0.01% | 962 |
|
|
2019
Q1 | $43.1M | Buy |
549,653
+11,858
| +2% | +$930K | 0.01% | 926 |
|
|
2018
Q4 | $45.5M | Buy |
537,795
+50,299
| +10% | +$4.26M | 0.01% | 862 |
|
|
2018
Q3 | $83.5M | Buy |
487,496
+20,916
| +4% | +$3.58M | 0.01% | 726 |
|
|
2018
Q2 | $60.3M | Buy |
466,580
+29,751
| +7% | +$3.84M | 0.01% | 819 |
|
|
2018
Q1 | $45M | Buy |
436,829
+23,040
| +6% | +$2.37M | 0.01% | 912 |
|
|
2017
Q4 | $35.3M | Buy |
413,789
+24,537
| +6% | +$2.1M | 0.01% | 995 |
|
|
2017
Q3 | $33.1M | Buy |
389,252
+20,214
| +5% | +$1.72M | 0.01% | 1004 |
|
|
2017
Q2 | $27.9M | Buy |
369,038
+16,138
| +5% | +$1.22M | 0.01% | 1048 |
|
|
2017
Q1 | $23.3M | Sell |
352,900
-390,292
| -53% | -$25.8M | ﹤0.01% | 1093 |
|
|
2016
Q4 | $47.1M | Sell |
743,192
-97,128
| -12% | -$6.16M | 0.01% | 828 |
|
|
2016
Q3 | $53.5M | Buy |
840,320
+28,901
| +4% | +$1.84M | 0.01% | 782 |
|
|
2016
Q2 | $60.4M | Buy |
811,419
+24,461
| +3% | +$1.82M | 0.01% | 714 |
|
|
2016
Q1 | $52.6M | Buy |
786,958
+19,140
| +2% | +$1.28M | 0.01% | 755 |
|
|
2015
Q4 | $51.9M | Buy |
767,818
+22,843
| +3% | +$1.55M | 0.01% | 753 |
|
|
2015
Q3 | $39.8M | Buy |
744,975
+2,725
| +0.4% | +$146K | 0.01% | 857 |
|
|
2015
Q2 | $46.7M | Buy |
742,250
+588,301
| +382% | +$37M | 0.01% | 865 |
|
|
2015
Q1 | $7.41M | Buy |
153,949
+15,229
| +11% | +$733K | ﹤0.01% | 1403 |
|
|
2014
Q4 | $4.61M | Sell |
138,720
-9,779
| -7% | -$325K | ﹤0.01% | 1473 |
|
|
2014
Q3 | $4.35M | Buy |
148,499
+2,565
| +2% | +$75.2K | ﹤0.01% | 1477 |
|
|
2014
Q2 | $5.67M | Buy |
145,934
+16,030
| +12% | +$623K | ﹤0.01% | 1438 |
|
|
2014
Q1 | $5.45M | Buy |
129,904
+24,205
| +23% | +$1.02M | ﹤0.01% | 1422 |
|
|
2013
Q4 | $3.47M | Buy |
105,699
+89,448
| +550% | +$2.93M | ﹤0.01% | 1468 |
|
|
2013
Q3 | $439K | Buy |
16,251
+1,603
| +11% | +$43.3K | ﹤0.01% | 1937 |
|
|
2013
Q2 | $342K | Buy |
+14,648
| New | +$342K | ﹤0.01% | 2018 |
|